Active Clearance Technology (ACT) Registry

Completed

Conditions studied: Retained Blood Syndrome

In brief

The purpose of this study is to evaluate the effectiveness of the PleuraFlow® Active Clearance Technology™ (ACT) System in the management of blood evacuation after cardiac surgery.

Key facts

Study ID

NCT02682849

Run by

John M. Stulak

People needed

500

Starts

2016-05-10

Expected to finish

2020-03-01

Last updated by the study team

2020-10-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or Female subjects 18 years of age or older who received a PleuraFlow System following heart surgery.
• Patient undergoing cardiac surgery via sternotomy

You may not qualify if…

• Robotic surgery
• Any access via thoracotomy
• Any condition deemed inappropriate for inclusion by the investigators.
• Intolerance to implantable silicone materials.

Where it is running

• Mayo Clinic — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.